LiMM
Description: LiMM is a Paris-based bio-pharma startup developing first-in-class NRILs by decoding neuroimmune cross-talk in peripheral tissues.
Country: France
Based in: Paris
Founded: 2017
Funding Stage: Seed
Tags: ['Bio-pharmaceutical', 'Health', 'Treatment']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
